Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/24 09:04 | 5/8/24 | CVM | Health | BioPrd | Biological Products, (No Diag | Watson Robert Eugene | GA | D | 1 | P | 28 | 1.39 | 0 | 20 | 451 | 24 | D | |||||||||||||||
5/9/24 13:07 | 5/8/24 | CVM | Health | BioPrd | Biological Products, (No Diag | Prichep Patricia B | VA | O | SVP | 1 | P | 11 | 1.39 | 0 | 8 | 4 | 232 | D | ||||||||||||||
5/9/24 09:19 | 5/8/24 | CVM | Health | BioPrd | Biological Products, (No Diag | Kersten Geert R | VA | DO | CEO | 1 | P | 42 | 1.39 | 0 | 30 | 3 | 1,195 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |